Cargando…
Benefits and harms of breast cancer screening: Cohort study of breast cancer mortality and overdiagnosis
BACKGROUND: Quantifying the benefits and harms of breast cancer screening accurately is important for planning and evaluating screening programs and for enabling women to make informed decisions about participation. However, few cohort studies have attempted to estimate benefit and harm simultaneous...
Autores principales: | Wang, Sabrina, Sultana, Farhana, Kavanagh, Anne, Nickson, Carolyn, Karahalios, Amalia, Gurrin, Lyle C., English, Dallas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524083/ https://www.ncbi.nlm.nih.gov/pubmed/37548277 http://dx.doi.org/10.1002/cam4.6373 |
Ejemplares similares
-
Mortality benefits and overdiagnosis estimates for women attending breast screening
por: Ormiston-Smith, N, et al.
Publicado: (2013) -
AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes
por: Nickson, Carolyn, et al.
Publicado: (2013) -
Overdiagnosis and breast cancer screening
por: Day, Nick E
Publicado: (2005) -
Overdiagnosis and overtreatment of breast cancer: Overdiagnosis in randomised controlled trials of breast cancer screening
por: Moss, Sue
Publicado: (2005) -
Overdiagnosis and overtreatment of breast cancer: Overdiagnosis and overtreatment in service screening
por: Paci, Eugenio, et al.
Publicado: (2005)